Scinai Immunotherapeutics (Scinai BioServices)

Israeli boutique CDMO (Jerusalem) offering peptide, recombinant protein, and antibody manufacturing. FDA and EMA cGMP-certified facility. Provides end-to-end development and manufacturing services from early stage through Phase 3 clinical trials. Specializes in peptides, proteins, and liposome formulations.

Scinai Immunotherapeutics (Scinai BioServices) is listed as a CDMO in the peptide supply chain, serving Asia markets from Israel (Jerusalem). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.